Author:
Böhm W.‑D. U.,Koch R.,Wenzel S.,Wirth M. P.,Toma M.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Arends TJH, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moscovitz B, van der Heijden AG, Witjes JA (2016) Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Guèrin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol 69:1046–1052
2. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, van Rhijn BW, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447–461
3. Böhle A, Jocham D (1998) Die intravesikale Immuntherapie mit Bacillus-Calmette-Guérin – Fakten, Vergleich, Ergebnisse. Fischer, Stuttgart, Jena, Lübeck
4. Demers V, Peisser V (2012) „BCGitis“: a rare case of tuberculous epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy. J Radiol Case Rep 6:16–21
5. Ehclaie B, Sylvester R, Herr HW (2013) Maintenance bacillus Calmette-Guérin treatment of non-muscle-bladder cancer. A critical evaluation oft he evidence. Eur Urol 64:579–585
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献